Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a systemic disease that leads to joint destruction. During the last decade, the therapy of RA has been principally based on biological drugs. Although the efficacy of biological therapy has been established, patients demonstrated a high heterogeneity in clinical response...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallio, Giovanni, Mannino, Federica, Irrera, Natasha, Eid, Ali H., Squadrito, Francesco, Bitto, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565539/
https://www.ncbi.nlm.nih.gov/pubmed/32825059
http://dx.doi.org/10.3390/biom10091203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565539/
https://www.ncbi.nlm.nih.gov/pubmed/32825059
http://dx.doi.org/10.3390/biom10091203

Ejemplares similares